ILCN.org (ILCN/WCLC) ILCN.org (ILCN/WCLC)
x/twitter facebook linkedin bluesky youtube instagram iaslc Home
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
Menu
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
loading...
Home Names & News

Global Insights into Smoking Cessation in Lung Cancer Screening

Rachael Murray, PhD, MS, BSc
+more
on: June 10, 2025In: Global Initiatives, Names & News, Tobacco Control & Smoking Cessation
Global Insights into Smoking Cessation in Lung Cancer Screening

Drs. Rachael Murray and Emma O’Dowd say despite increasing evidence that cessation efforts within screening programs are effective, a lack of clear guidance means this opportunity is often missed. Read more


Overcoming Resistance Remains a Challenge in Targeting KRAS

Haleigh Behrman
on: May 27, 2025In: Evolving Standards of Care, Meeting News, Names & News, Society News
Overcoming Resistance Remains a Challenge in Targeting KRAS

Dana-Farber's Dr. Alice Shaw recently explored various combination strategies that show promise in preventing or delaying resistance in this previously undruggable space. Read more

Pathology Researcher Keith Kerr Receives 2025 Heine H. Hansen Award

Nathan Pettengill
on: April 08, 2025In: Meeting News, Names & News, Society News
Pathology Researcher Keith Kerr Receives 2025 Heine H. Hansen Award

During his award lecture at the European Lung Cancer Congress, Dr. Kerr said lung cancer treatment has benefited from the bridging of the historical divide between pathology and medical oncology. Read more

Combination Therapies as Frontline Treatment for EGFR-Mutated NSCLC: Are the Rewards Worth the Risks?

Haleigh Behrman
on: March 25, 2025In: Evolving Standards of Care, Meeting News, Names & News
Combination Therapies as Frontline Treatment for EGFR-Mutated NSCLC: Are the Rewards Worth the Risks?

During a TTLC debate, Drs. Helena Yu and Shirish Gadgeel weighed the pros and limitations of osimertinib monotherapy and combination therapies. Read more

With Data on Her Side, Dr. Anne Tsao Dominates Debate on Merits of Chemo-IO for Mesothelioma

Haleigh Behrman
on: March 25, 2025In: Evolving Standards of Care, Meeting News, Names & News
With Data on Her Side, Dr. Anne Tsao Dominates Debate on Merits of Chemo-IO for Mesothelioma

Lacking evidence to argue against combinations in this patient population, Dr. Penelope Bradbury, turned to humor to make her case. Read more

Will Bispecific Antibodies Replace PD-(L)1 Targeted Agents?

Nathan Pettengill
on: March 11, 2025In: Meeting News, Names & News, Society News
Will Bispecific Antibodies Replace PD-(L)1 Targeted Agents?

Drs. Jonathan W. Riess and Greg Kalemkerian present opposing views regarding the therapeutic potential of novel targeted therapies. Read more

Debate Leaves Audience Unconvinced that KRAS Inhibitors Deserve Promotion to First-Line Treatment

Nathan Pettengill
on: March 11, 2025In: Meeting News, Names & News, Society News
Debate Leaves Audience Unconvinced that KRAS Inhibitors Deserve Promotion to First-Line Treatment

While Dr. Trever Bivona argued that KRAS inhibitors will join other seminal oncogene inhibitors, Dr. Rebecca Heist said the data has yet to demonstrate they outperform the current second-line standard of care. Read more

Breaking the Silence: The #HearHer Campaign for Women with Lung Cancer

Lauren Kiel, BS
+more
on: February 11, 2025In: Names & News, Patient Advocacy, Screening/ED
Breaking the Silence: The #HearHer Campaign for Women with Lung Cancer

Narjust Florez, MD, and Angela Morabito, BS, launched the #HearHer campaign to raise awareness about the increasing incidence of lung cancer among women and the frequent delays in diagnosis. Read more

Oncology Trialists and Their Minions

Corey J. Langer, MD, FACP
on: February 11, 2025In: Names & News
Oncology Trialists and Their Minions

Poet and ILCN Editor-in-Chief Corey Langer, MD, illustrates the build-up and anticipation surrounding the release of research data. Read more

No “Known” Risk Factors: The Health Consequences of Radiation Therapy

Heidi Nafman-Onda
on: January 07, 2025In: Names & News, Patient Advocacy, Radiation Oncology
No “Known” Risk Factors: The Health Consequences of Radiation Therapy

Heidi Nafman-Onda, founder of The White Ribbon Project, shares her experience discovering and grappling with the long-term effects of radiation therapy and addresses the need for coordinated survivorship care. Read more

1234›»

SEARCH ILCN

Archives

PROVIDER RESOURCES

MARIPOSA OS Data Confirms Improved Efficacy for Amivantamab Plus Lazertinib in the First Line for EGFR-mutated NSCLC

INDUSTRY SUPPORTED


COCOON’s Prophylactic Regimen Resulted in Decreased Incidence and Severity of Dermatologic-related Adverse Events

INDUSTRY SUPPORTED

POPULAR ARTICLES

Discussion Covered Updates, Strategies, and Controversies in Lung Cancer Staging
No “Known” Risk Factors: The Health Consequences of Radiation Therapy
Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture
WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers
Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC
IASLC Logo
ILCN Editorial Group    IASLC.org   

Advertise with Us   

© 2024 IASLC. All Rights Reserved. Powered By TriStar Event Media, LLC   Privacy Policy